Patent details

EP2779992 Title: SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2

Basic Information

Publication number:
EP2779992
PCT Application Number:
US2012064988
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127880920
PCT Publication Number:
WO2013074610
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2
French Title of Invention:
PRÉPARATION À EFFET PROLONGÉ DE LA FORME 2 DE LA CYCLOSPORINE
German Title of Invention:
FORMULIERUNG VON CYCLOSPORIN DER FORM 2 MIT VERLÄNGERTER WIRKUNG
SPC Number:

Dates

Filing date:
14/11/2012
Grant date:
28/02/2018
EP Publication Date:
24/09/2014
PCT Publication Date:
23/05/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/02/2018
EP B1 Publication Date:
28/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/11/2018
Expiration date:
14/11/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/02/2018
 
 

Name:
ALLERGAN, INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:
ATTAR, Mayssa
Address:
United States (US)

2

Name:
BLANDA, Wendy M.
Address:
United States (US)

Priority

1

Priority Number:
201161559838 P
Priority Date:
15/11/2011
Priority Country:
United States (US)

2

Priority Number:
201161563199 P
Priority Date:
23/11/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/10; A61K 38/13; A61K 47/32; A61K 47/36; A61K 47/38; C07K 1/30; C07K 7/64;

Publication

European Patent Bulletin

1

Issue number:
201809
Publication date:
28/02/2018
Description:
Grant (B1)

2

Issue number:
201814
Publication date:
04/04/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1